Related Experiment Video
Updated: Jun 14, 2025
08:11
Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells
Published on: August 7, 2021
4.1K
Role of PRMT1 and PRMT5 in Breast Cancer
Sébastien Martinez1,2, Stéphanie Sentis1,2, Coralie Poulard1,2
1Inserm U1052, Centre de Recherche en Cancérologie de Lyon, Université Claude Bernard Lyon 1, F-69000 Lyon, France.
International Journal of Molecular Sciences
|August 29, 2024
Summary
Protein arginine methyltransferases (PRMTs) regulate breast cancer development. PRMT1 and PRMT5 are key targets for treating breast cancer, a heterogeneous and often incurable disease.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Breast cancer is a leading cause of cancer death in women globally.
- It is a heterogeneous disease with varying subtypes and treatment strategies.
- Epigenetic modifications, including arginine methylation, play a role in breast cancer initiation and progression.
Purpose of the Study:
- To provide an updated overview of how Protein Arginine Methyltransferases (PRMTs) regulate breast cancer.
- To highlight the roles of PRMT1 and PRMT5 in breast tumorigenesis.
- To identify PRMT1 and PRMT5 as potential therapeutic targets for breast cancer.
Main Methods:
- Review of current scientific literature on PRMTs and breast cancer.
- Analysis of the mechanisms by which PRMT1 and PRMT5 influence signaling pathways.
- Identification of key substrates and pathways regulated by PRMT1 and PRMT5.
Main Results:
- PRMT1 and PRMT5 are crucial regulators of signaling pathways involved in breast cancer.
- These enzymes influence key processes such as cell proliferation, apoptosis, and DNA repair.
- Aberrant PRMT activity is linked to various stages of breast tumor development.
Conclusions:
- PRMT1 and PRMT5 are essential regulators in breast cancer.
- Targeting PRMT1 and PRMT5 offers a promising therapeutic strategy for breast cancer treatment.
- Further research into PRMT-mediated epigenetic modifications is warranted for novel cancer therapies.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
02:55The Nucleolus
8.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
01:22MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K